Expansion of mesenchymal stem cells on fibrinogen-rich protein surfaces derived from blood plasma
Corresponding Author
John D. Kisiday
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Orthopedic Research Center, Colorado State University, 300 W. Drake Road, Fort Collins, CO 80523, USA.Search for more papers by this authorBenjamin W. Hale
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorJorge L. Almodovar
Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorChristina M. Lee
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorMatt J. Kipper
Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorC. Wayne McIlwraith
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorDavid D. Frisbie
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorCorresponding Author
John D. Kisiday
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Orthopedic Research Center, Colorado State University, 300 W. Drake Road, Fort Collins, CO 80523, USA.Search for more papers by this authorBenjamin W. Hale
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorJorge L. Almodovar
Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorChristina M. Lee
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorMatt J. Kipper
Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorC. Wayne McIlwraith
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorDavid D. Frisbie
Orthopedic Research Center, Department of Clinical Science, Colorado State University, Fort Collins, CO, USA
Search for more papers by this authorAbstract
Mesenchymal stem cells (MSCs) are present in low density in bone marrow and culture expansion is necessary to obtain sufficient numbers for many proposed therapies. Researchers have characterized MSC growth on tissue culture plastic (TCP), although few studies have explored proliferation on other growth substrates. Using adult equine MSCs, we evaluated proliferation on fibrinogen-rich precipitate (FRP) surfaces created from blood plasma. When seeded at 1 × 104 cells/cm2 and passaged five times over 10 days, MSCs on FRP in medium containing fibroblast growth factor 2 (FGF2) resulted in a ∼2.5-fold increase in cell yield relative to TCP. In FGF2-free medium, FRP stimulated a 10.4-fold increase in cell yield over TCP after 10 days, although control cultures maintained in FGF2 on TCP demonstrated that the stimulatory effect of FRP was not as lasting as that of FGF2. Chondrogenic cultures demonstrated that FRP did not affect differentiation. On TCP, MSCs seeded at 500 cells/cm2 experienced a 4.6-fold increase in cell yield over cultures seeded at 1 × 104 cells/cm2 following 10 days of expansion. In 500 cells/cm2 cultures, FRP stimulating a two-fold increase in cell yield over TCP without affecting differentiation. Low-density FRP cultures showed a more even distribution of cells than TCP, suggesting that FRP may accelerate proliferation by reducing contact inhibition that slows proliferation. In addition, FRP appears capable of binding FGF2, as FRP surfaces pre-conditioned with FGF2 supported greater proliferation than FGF2-free cultures. Taken together, these factors indicate that substrates obtained from simple and inexpensive processing of blood enhance MSC proliferation and promote efficient coverage of expansion surfaces. Copyright © 2010 John Wiley & Sons, Ltd.
References
- Ahmed TA, Dare EV, Hincke M. 2008; Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng B Rev 14(2): 199–215.
- Bensaid W, Triffitt JT, Blanchat C, et al. 2003; A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24(14): 2497–2502.
- Bianchi G, Banfi A, Mastrogiacomo M, et al. 2003; Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287(1): 98–105.
- Boddohi S, Killingsworth CE, Kipper MJ. 2008; Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin. Biomacromolecules 9(7): 2021–2028.
- Bruder SP, Jaiswal N, Haynesworth SE. 1997; Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64(2): 278–294.
10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F CAS PubMed Web of Science® Google Scholar
- Caplan AI. 2007; Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213(2): 341–347.
- Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, et al. 2008; Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol 36(8): 1014–1021.
- Colter DC, Class R, DiGirolamo CM, Prockop DJ. 2000; Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97(7): 3213–3218.
- Desroches MJ, Omanovic S. 2008; Adsorption of fibrinogen on a biomedical-grade stainless steel 316LVM surface: a PM-IRRAS study of the adsorption thermodynamics, kinetics and secondary structure changes. Phys Chem Chem Phys 10(18): 2502–2512.
- DiGirolamo CM, Stokes D, Colter D, et al. 1999; Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107(2): 275–281.
- D'Ippolito G, Diabira S, Howard GA, et al. 2004; Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 117(14): 2971–2981.
- Doucet C, Ernou I, Zhang Y, et al. 2005; Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205(2): 228–236.
- Evans CH, Palmer GD, Pacher A, et al. 2007; Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 13(8): 1987–1993.
- Frisbie DD, Bowman SM, Colhoun HA, et al. 2008; Evaluation of autologous chondrocyte transplantation via a collagen membrane in equine articular defects: results at 12 and 18 months. Osteoarthr Cartilage 16(6): 667–679.
- Gailit J, Clarke C, Newman D, et al. 1997; Human fibroblasts bind directly to fibrinogen at RGD sites through integrin αvβ3. Exp Cell Res 232(1): 118–126.
- Greiling D, Clark RA. 1997; Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 110(7): 861–870.
- Hashimoto J, Kariya Y, Miyazaki K. 2006; Regulation of proliferation and chondrogenic differentiation of human mesenchymal stem cells by laminin-5 (laminin-332). Stem Cells 24(11): 2346–2354.
- Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. 1992; Characterization of cells with osteogenic potential from human marrow. Bone 13(1): 81–88.
- Ho W, Tawil B, Dunn JC, Wu BM. 2006; The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng 12(6): 1587–1595.
- Huang CY, Deitzer MA, Cheung HS. 2007; Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels. Biomech Model Mechanobiol 6(1–2): 5–11.
- Huang CY, Reuben PM, D'Ippolito G, et al. 2004; Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 278(1): 428–436.
- Ito T, Sawada R, Fujiwara Y, et al. 2007; FGF-2 suppresses cellular senescence of human mesenchymal stem cells by downregulation of TGF-β2. Biochem Biophys Res Commun 359(1): 108–114.
- Javazon EH, Beggs KJ, Flake AW. 2004; Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32(5): 414–425.
- Javazon EH, Colter DC, Schwarz EJ, Prockop DJ. 2001; Rat marrow stromal cells are more sensitive to plating density and expand more rapidly from single-cell-derived colonies than human marrow stromal cells. Stem Cells 19(3): 219–225.
- Johnstone B, Hering TM, Caplan AI, et al. 1998; In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238(1): 265–272.
- Kisiday JD, Kopesky PW, Evans CH, et al. 2008; Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 26(3): 322–331.
- Lange C, Cakiroglu F, Spiess AN, et al. 2007; Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transniantation and regenerative medicine. J Cell Physiol 213(1): 18–26.
- Larson BL, Ylostalo J, Prockop DJ. 2008; Human multipotent stromal cells undergo sharp transition from division to development in culture. Stem Cells 26(1): 193–201.
- Lee KB, Hui JH, Song IC, et al. 2007; Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model. Stem Cells 25(11): 2964–2971.
- Mannello F, Tonti GA. 2007; Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned medium, or ad hoc formula? All that glitters is not gold! Stem Cells 25(7): 1603–1609.
- Mareddy SR, Crawford R, Brooke G, Xiao Y. 2007; Clonal isolation and characterization of bone marrow stromal cells from osteoarthritis patients. Bone 40(6): S168–168.
- Martin I, Muraglia A, Campanile G, et al. 1997; Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138(10): 4456–4462.
- Matsubara T, Tsutsumi S, Pan H, et al. 2004; A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix. Biochem Biophys Res Commun 313(3): 503–508.
- Mauck RL, Yuan X, Tuan RS. 2006; Chondrogenic differentiation and functional maturation of bovine mesenchymal stem cells in long-term agarose culture. Osteoarthr Cartilage 14(2): 179–189.
- Mauney JR, Volloch V, Kaplan DL. 2005; Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion. Biomaterials 26(31): 6167–6175.
- Murphy JM, Fink JD, Hunziker EB, Barry FP. 2003; Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48(12): 3464–3474.
- Muschler GF, Nitto H, Boehm CA, Easley KA. 2001; Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 19(1): 117–125.
- Neuhuber B, Swanger SA, Howard L, et al. 2008; Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp Hematol 36(9): 1176–1185.
- Phinney DG, Kopen G, Righter W, et al. 1999; Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 75(3): 424–436.
10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8 CAS PubMed Web of Science® Google Scholar
- Sah RL, Kim YJ, Doong JY, et al. 1989; Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res 7(5): 619–636.
- Sahni A, Odrljin T, Francis CW. 1998; Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem 273(13): 7554–7559.
- Sahni A, Sporn LA, Francis CW. 1999; Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J Biol Chem 274(21): 14936–14941.
- Salvade A, Della Mina P, Gaddi D, et al. 2009; Characterization of platelet lysate (PL)-cultured mesenchymal stromal cells (MSC) and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng C Methods 16(2): 201–214.
- Schmal H, Niemeyer P, Roesslein M, et al. 2007; Comparison of cellular functionality of human mesenchymal stromal cells and PBMC. Cytotherapy 9(1): 69–79.
- Schuleri KH, Amado LC, Boyle AJ, et al. 2008; Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol 294(5): H2002–2011.
- Shahdadfar A, Fronsdal K, Haug T, et al. 2005; In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 23(9): 1357–1366.
- Siddappa R, Licht R, van Blitterswijk C, de Boer J. 2007; Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 25(8): 1029–1041.
- Silver FH, Wang MC, Pins GD. 1995a; Preparation and use of fibrin glue in surgery. Biomaterials 16(12): 891–903.
- Silver FH, Wang MC, Pins GD. 1995b; Preparation of fibrin glue: a study of chemical and physical methods. J Appl Biomater 6(3): 175–183.
- Solchaga LA, Penick K, Porter JD, et al. 2005; FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203(2): 398–409.
- Sotiropoulou PA, Perez SA, Salagianni M, et al. 2006; Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells 24(2): 462–471.
- Stolzing A, Jones E, McGonagle D, Scutt A. 2008; Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 129(3): 163–173.
- Stute N, Holtz K, Bubenheim M, et al. 2004; Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol 32(12): 1212–1225.
- Tunc S, Maitz MF, Steiner G, et al. 2005; In situ conformational analysis of fibrinogen adsorbed on Si surfaces. Colloids Surf B Biointerfaces 42(3–4): 219–225.
- Vidal MA, Kilroy GE, Johnson JR, et al. 2006; Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 35(7): 601–610.
- Wakitani S, Goto T, Pineda SJ, et al. 1994; Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am 76(4): 579–592.
- Wang J, Chen X, Clarke ML, Chen Z. 2006; Vibrational spectroscopic studies on fibrinogen adsorption at polystyrene/protein solution interfaces: hydrophobic side chain and secondary structure changes. J Phys Chem B 110(10): 5017–5024.
- Wilke MM, Nydam DV, Nixon AJ, et al. 2007; Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25(7): 913–925.
- Worster AA, Brower-Toland BD, Fortier LA, et al. 2001; Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-β1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19(4): 738–749.
- Yoshida H, Hirozane K, Kamiya A. 1999; Comparative study of autologous fibrin glues prepared by cryo-centrifugation, cryo-filtration, and ethanol precipitation methods. Biol Pharm Bull 22(11): 1222–1225.
- Zangi L, Rivkin R, Kassis I, et al. 2006; High-yield isolation, expansion, and differentiation of rat bone marrow-derived mesenchymal stem cells with fibrin microbeads. Tissue Eng 12(8): 2343–2354.
- Zhou S, Greenberger JS, Epperly MW, et al. 2008; Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7(3): 335–343.